113 results
Page 2 of 6
8-K
EX-99.1
q1qkn
23 Sep 22
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
4:53pm
8-K
EX-10.1
3ep4 44ux
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-99.1
fhqvklgh
26 Jul 22
InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
1:32pm
8-K
EX-10.1
vax1 oetba
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B3
zwgz07036 8e
6 Jul 22
Prospectus supplement
2:43pm
8-K
EX-10.1
tc5hvbdefv4r0k4qtx8
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
3qwch
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
s3nj9ohuchf4pku1
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
egjde2saacgm09gpr3
18 May 22
InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
1:34pm
8-K
EX-99.1
4lk0 9d3m
28 Apr 22
Regulation FD Disclosure
2:35pm
424B3
51kgem6d5vsnve5lp6
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
gvsarkztu93
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
vzlmh243 nwqiviyyt
7 Apr 22
Prospectus supplement
4:46pm